Serum 25‐hydroxyvitamin D concentration does not independently predict incident diabetes in older women

Abstract Aims To investigate whether 25‐hydroxyvitamin D concentration was associated with incident diabetes in a large cohort of older women. Methods Data were analysed from women included in the Study of Osteoporotic Fractures, a cohort of community‐dwelling women aged ≥65 years at enrolment. Serum 25‐hydroxyvitamin D concentration was assessed at the year 6 visit, as were BMI and other factors associated with vitamin D and/or diabetes. Diabetes status was determined at each subsequent visit by self‐report and medication use. Only those without prevalent diabetes at the year 6 visit were included in the present analysis ( N  =   5463, mean age 76.5 years). Results During a mean ± sd follow‐up of 8.6 ± 4.4 years, incident diabetes was reported in 320 participants. The mean BMI was higher in those with a 25‐hydroxyvitamin D concentration <20 ng/ml (<50 nmol/l) than in those with concentrations 20–30 or ≥30 ng/ml [50–74 or ≥75 nmol/l ( P  <   0.0001)]. A higher 25‐hydroxyvitamin D concentration was associated with a 13% lower risk of incident diabetes after adjustment for age and clinic site [hazard ratio 0.87, 95% CI 0.76–0.99, per sd increase in 25‐hydroxyvitamin D]; however, the addition of BMI to the model attenuated the estimated effect (hazard ratio 0.97, 95% CI 0.86–1.11). Adjustment for additional potential confounders yielded similar results. Conclusions Serum 25‐hydroxyvitamin D does not independently predict incident diabetes in older women. Although those with higher 25‐hydroxyvitamin D concentrations are less likely to develop diabetes, this is mainly explained by their lower BMI .